Bayer to test antibiotic on TB

Oct. 19, 2005 at 3:06 AM

NEW YORK, Oct. 19 (UPI) -- The German pharmaceutical company Bayer HealthCare plans tests to determine if its newest antibiotic is effective against tuberculosis.

The New York Times said that no new drugs against tuberculosis have been registered in 40 years. Most drug companies do not test patented pharmaceuticals against diseases associated with poverty.

Bayer said that if moxifloxacin shortens TB treatment it will provide millions of doses for poor countries.

The trials are being funded by the Bill and Melinda Gates Foundation and by the Centers for Disease Control and Prevention, the new European and Developing Countries Clinical Trials Partnership and the Food and Drug Administration.

Like Us on Facebook for more stories from UPI.com  
Latest Headlines
Top Stories
Finland orders anti-tank weapon from Saab
Orbital ATK's artillery guidance kit passes milestone test
Fourth MUOS arrives in Florida for August launch
Oil prices drop on Greek, Iran concerns
North Dakota rig data suggests stability